(Q24318606)

4

object named as

G Hale

0 references

author name string

M Q Xia

1

0 references

M Tone

2

0 references

L Packman

European Journal of Immunology

3

0 references

language of work or name

English

0 references

publication date

July 1991

0 references

published in

0 references

volume

21

0 references

issue

7

0 references

page(s)

1677-84

0 references

cites work

Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

Preparation of monoclonal antibodies against a glycolipid asialo GM1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

The CAMPATH-1 antigen (CDw52)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Phosphatidylinositol is the membrane-anchoring domain of the Thy-1 glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Isolation of low-frequency class-switch variants from rat hybrid myelomás

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

A procedure for the quantitative isolation of brain gangliosides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Generation of cDNA probes directed by amino acid sequence: cloning of urate oxidase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

High-copy-number and low-copy-number plasmid vectors for lacZ alpha-complementation and chloramphenicol- or kanamycin-resistance selection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Improved tools for biological sequence comparison

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Hematopoietic subpopulations express cross-reactive, lineage-specific molecules detected by monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Cell-surface markers on haemopoietic precursors. Reagents for the isolation and analysis of progenitor cell subpopulations.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Pancreatic islet cell surface glycoproteins containing Gal beta 1-4GlcNAc-R identified by a cytotoxic monoclonal autoantibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021

Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830210714

7 January 2021